Research Articles
Hepatitis C's Hidden Danger: Why Genotype 3 Poses a Special Cancer Risk
Exploring the systematic evidence behind HCV genotype 3's dangerous connection to hepatocellular carcinoma and increased cancer risk even after successful treatment.
Beyond the Liver: How Curing Hepatitis C is Revolutionizing Diabetes Care
Exploring how direct-acting antiviral agents for hepatitis C are improving diabetes outcomes through metabolic pathways
Hepatitis C: The Silent Pandemic We're Learning to Cure
Explore the scientific breakthroughs in hepatitis C research from 2013-2022, from discovery to cure and elimination challenges.
Hepatitis C Treatment Revolution: How Combination Antiviral Therapy Changed the Game
Explore the remarkable scientific journey toward hepatitis C treatment optimization with combination direct-acting antiviral therapy that has transformed a chronic infection into a curable condition.
When Two Drugs Are Better Than One: A Retreatment Battle Against Hepatitis C
Discover how the combination of interferon and ribavirin revolutionized hepatitis C treatment for patients who failed initial interferon therapy.
Catching the Ghost: The Modern Battle Against Acute Hepatitis C
Explore the cutting-edge pharmacological interventions transforming acute hepatitis C from a potential lifelong threat into a curable condition.
Hepatitis C Revolution: How the 2016 Treatment Guidelines Changed Everything
Explore how the 2016 JSH guidelines transformed hepatitis C treatment with direct-acting antivirals, achieving cure rates over 95% for genotypes 1 and 2.
The Hidden Battle in Your Liver: How a Viral Protein Fuels Scar Formation
Exploring how Hepatitis C Virus's NS3 protease triggers liver fibrosis by activating stellate cells and disrupting miR-122 expression
From Dialysis to Cure: How New Antivirals Are Revolutionizing Hepatitis C Treatment in Kidney Patients
Explore how direct-acting antivirals (DAAs) are transforming hepatitis C treatment for patients with chronic kidney disease, achieving cure rates exceeding 95% even in end-stage renal disease.
The Silent Epidemic: Hepatitis C and HIV Co-Infection in Rural Cameroon
Exploring the prevalence and risk factors of HCV and HIV co-infection in rural Cameroon through a groundbreaking population study.